Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
July 30, 2022 at 07:19 am EDT
Venmax Drugs and Pharmaceuticals Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported revenue was INR 0.5 million. Net income was INR 0.297 million compared to net loss of INR 0.342 million a year ago. Basic earnings per share from continuing operations was INR 0.06 compared to basic loss per share from continuing operations of INR 0.07 a year ago. Diluted earnings per share from continuing operations was INR 0.06 compared to diluted loss per share from continuing operations of INR 0.07 a year ago.